Exchange: NASDAQ·Updated 03:09 PM EDT

BPTS Biophytis SA ADR

$0.25
$0.00
(0.00%)
Today
Mkt Cap$8.75M
Vol10.00

About BPTS

Biophytis SA operates as a clinical-stage biotechnology company. It specializes in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19. Its products include Sarconeos (BIO101), which is used to treat sarcopenic obesity and Macuneos (BIO201), which is used to treat dry age-related macular degeneration (AMD). The company was founded by Stanislas Veillet and René Lafont on September 27, 2006 and is headquartered in Paris, France.
60

Bullish Sentiment

How do you feel about BPTS?

Advertisement|Remove ads.